
<mods xmlns="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-4.xsd">
    
    <titleInfo>
        <title>Supervision of Facilitators in a Multisite Study: Goals, Process, and Outcomes</title>
    </titleInfo>
    <name type="personal" ID="ew157">
        <namePart type="family">Wu</namePart>
        <namePart type="given">Elwin</namePart>
        <role>
            <roleTerm type="text">contributor</roleTerm>
        </role>
        <affiliation>Columbia University. Social Work</affiliation>
    </name>
    <name type="personal" ID="ssw12">
        <namePart type="family">Witte</namePart>
        <namePart type="given">Susan S.</namePart>
        <role>
            <roleTerm type="text">contributor</roleTerm>
        </role>
        <affiliation>Columbia University. Social Work</affiliation>
    </name>
    <name type="personal" ID="ne5">
        <namePart type="family">El-Bassel</namePart>
        <namePart type="given">Nabila</namePart>
        <role>
            <roleTerm type="text">contributor</roleTerm>
        </role>
        <affiliation>Columbia University. Social Work</affiliation>
    </name>
    <name type="personal" ID="lg123">
        <namePart type="family">Gilbert</namePart>
        <namePart type="given">Louisa</namePart>
        <role>
            <roleTerm type="text">contributor</roleTerm>
        </role>
        <affiliation>Columbia University. Social Work</affiliation>
    </name>
    <name type="corporate">
        <namePart>NIMH Multisite HIV/STD Prevention Trial for African American Couples Group</namePart>
        <role>
            <roleTerm type="text">author</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>Columbia University. Social Work</namePart>
        <role>
            <roleTerm type="text">originator</roleTerm>
        </role>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre>Articles</genre>
    
    <originInfo>
        <dateIssued encoding="w3cdtf" keyDate="yes">2008</dateIssued>
        <edition>manuscript version</edition>
    </originInfo>
    
    <language>
        <languageTerm type="text">English</languageTerm>
    </language>
    <abstract>Objective: To describe the aims, implementation, and desired outcomes of facilitator supervision for both interventions (treatment and control) in Project Eban and to present the Eban Theoretical Framework for Supervision that guided the facilitators’ supervision. The qualifications and training of supervisors and facilitators are also described. Design: This article provides a detailed description of supervision in a multisite behavioral intervention trial. The Eban Theoretical Framework for Supervision is guided by 3 theories: cognitive behavior therapy, the Life-long Model of Supervision, and &quot;Empowering supervisees to empower others: a culturally responsive supervision model.&quot; Methods: Supervision is based on the Eban Theoretical Framework for Supervision, which provides guidelines for implementing both interventions using goals, process, and outcomes. Results: Because of effective supervision, the interventions were implemented with fidelity to the protocol and were standard across the multiple sites. Conclusions: Supervision of facilitators is a crucial aspect of multisite intervention research quality assurance. It provides them with expert advice, optimizes the effectiveness of facilitators, and increases adherence to the protocol across multiple sites. Based on the experience in this trial, some of the challenges that arise when conducting a multisite randomized control trial and how they can be handled by implementing the Eban Theoretical Framework for Supervision are described.</abstract>
    <subject>
        <topic>Behavioral sciences</topic>
    </subject>
    <subject>
        <topic>Public health</topic>
    </subject>
    <relatedItem type="host">
        <titleInfo>
            <title>Journal of Acquired Immune Deficiency Syndromes</title>
        </titleInfo>
        <part>
            <detail type="volume">
                <number>49</number>
            </detail>
            <detail type="issue">
                <number>Supplement 1</number>
            </detail>
            <extent unit="page">
                <start>S59</start>
                <end>S67</end>
            </extent>
            <date>2008-09-01</date>
        </part>
        <identifier type="doi">http://dx.doi.org/10.1097/QAI.0b013e3181844807</identifier>
        <identifier type="issn">1525-4135</identifier>
    </relatedItem>
    <identifier type="hdl">http://hdl.handle.net/10022/AC:P:14282</identifier>
    
    <location>
        <physicalLocation authority="marcorg">NNC</physicalLocation>
    </location>
    
    <recordInfo>
        <recordContentSource authority="marcorg">NNC</recordContentSource>
        <recordCreationDate encoding="w3cdtf">2012-07-30 15:53:28 -0400</recordCreationDate>
        <recordChangeDate encoding="w3cdtf">2013-05-03 16:38:13 -0400</recordChangeDate>
        <recordIdentifier>8289</recordIdentifier>
        <languageOfCataloging>
            <languageTerm authority="iso639-2b">eng</languageTerm>
        </languageOfCataloging>
    </recordInfo>
    
</mods>
